Lowenthal Richard E 4
4 · ARS Pharmaceuticals, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Lowenthal Richard E
DirectorPRESIDENT AND CEO10% Owner
Transactions
- Award
Stock option (right to buy)
2026-01-02+875,000→ 875,000 totalExercise: $11.49Exp: 2036-01-01→ Common Stock (875,000 underlying) - Award
Stock Option (right to buy)
2026-01-02+240,000→ 240,000 total(indirect: By Spouse)Exercise: $11.49Exp: 2036-01-01→ Common Stock (240,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2026.